CLINICAL_TRIALS trial_result · 2014-09-12

Clinical Trial Update: Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Primary CNS Lymphoma [Phase 2]

Phase 2 study evaluating rituximab in combination chemotherapy for newly diagnosed primary central nervous system lymphoma; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Lymphoma | Phase 2 | Status: COMPLETED | Results posted: 2014-09-12